Mosaic Family Wealth LLC purchased a new position in shares of CME Group Inc (NASDAQ:CME) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 1,000 shares of the financial services provider’s stock, valued at approximately $211,000.
Several other large investors also recently bought and sold shares of the business. Nuveen Asset Management LLC increased its holdings in shares of CME Group by 18,355.3% during the 2nd quarter. Nuveen Asset Management LLC now owns 3,238,530 shares of the financial services provider’s stock worth $628,631,000 after acquiring an additional 3,220,982 shares during the last quarter. Parnassus Investments CA acquired a new position in shares of CME Group during the 2nd quarter worth approximately $544,292,000. Magellan Asset Management Ltd acquired a new position in shares of CME Group during the 2nd quarter worth approximately $418,297,000. Fiera Capital Corp increased its holdings in shares of CME Group by 17.0% during the 2nd quarter. Fiera Capital Corp now owns 2,960,477 shares of the financial services provider’s stock worth $574,658,000 after acquiring an additional 429,235 shares during the last quarter. Finally, Amundi Pioneer Asset Management Inc. increased its holdings in shares of CME Group by 30.4% during the 2nd quarter. Amundi Pioneer Asset Management Inc. now owns 1,664,500 shares of the financial services provider’s stock worth $323,097,000 after acquiring an additional 388,008 shares during the last quarter. 84.90% of the stock is currently owned by hedge funds and other institutional investors.
In other CME Group news, insider Sean Tully sold 7,200 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $223.13, for a total value of $1,606,536.00. Following the transaction, the insider now owns 19,923 shares in the company, valued at $4,445,418.99. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $200.15, for a total value of $7,005,250.00. Following the completion of the transaction, the chief executive officer now owns 79,057 shares in the company, valued at approximately $15,823,258.55. The disclosure for this sale can be found here. Insiders have sold 57,126 shares of company stock valued at $11,752,684 in the last ninety days. 1.20% of the stock is currently owned by insiders.
CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, topping the consensus estimate of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The business had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same quarter last year, the firm posted $1.74 earnings per share. The firm’s revenue was up 20.1% on a year-over-year basis. Equities analysts expect that CME Group Inc will post 6.83 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th were paid a dividend of $0.75 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $3.00 annualized dividend and a yield of 1.48%. CME Group’s dividend payout ratio is currently 43.99%.
CME has been the subject of several recent research reports. BidaskClub downgraded CME Group from a “buy” rating to a “hold” rating in a research note on Friday, October 18th. ValuEngine cut CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Berenberg Bank cut CME Group from a “buy” rating to a “hold” rating and lowered their target price for the stock from $236.00 to $227.00 in a report on Thursday, September 19th. Oppenheimer assumed coverage on CME Group in a research note on Monday, September 16th. They issued an “outperform” rating and a $234.00 price target for the company. Finally, Wells Fargo & Co increased their price target on CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research note on Wednesday, July 3rd. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have given a buy rating to the company. CME Group has an average rating of “Hold” and a consensus target price of $203.14.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Story: What are retained earnings?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.